[ 1 ] Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002[J]. CA Cancer J Clin, 2002, 55(2): 74-108.
[2]
[ 2 ] Peto J, Gilham C, Fletcher O, et al. The cervical cancer epidemic that screening has prevented in the UK[J]. Lancet, 2004, 364(9430): 249-256.
[3]
[ 3 ] Sauvaget C. Fayette JM. Muwonge R, et al. Accuracy of visual inspection with acetic acid for cervical cancer screening[J]. Int J Gynecol Obstet, 2011, 113(1): 14-24.
[4]
[ 4 ] Everett T, Bryant A, Griffin MF, et al. Interventions targeted at women to encourage the uptake of cervical screening[J]. Cochrane Database Syst Rev, 2011(5): CD002834.
[5]
[ 5 ] IARC Working Group on evaluation ofcervical cancer screening programmes. Screening for squamous cervical cancer: duration of low risk after negative results of cervicalcytology and its implication for screening policies[J]. Br Med J, 1986, 293(6548): 659-664.
[ 7 ] Siebers AG, Klinkhamer PJ, Grefte JM, et al. Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors:a randomized controlled trial[J]. JAMA, 2009, 302(16): 1757-1765.
[8]
[ 8 ] Ronco G, Cuzick J, Pierotti P, et al. Accuracy of liquid based versus conventional cytology:overall results of new technologies for cervical cancer screening:randomised controlled trial[J]. BMJ, 2007, 335(7609): 28.
[9]
[ 9 ] de Sanjose S, Quint WG, Alemany L, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study[J]. Lancet Oncol, 2010, 11(11): 1048-1056.
[10]
Mayrand MH, Duarte-Franco E, Rodrigues I, et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer[J]. NEJM, 2007, 357(16): 1579-1588.
[11]
Wright TC Jr, Schiffman M, Solomon D, et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening[J]. Obstet Gynecol, 2004, 103(2): 304-309.
[12]
Reich O, Pickel H, Tamussino K, et al. Microinvasive carcinoma of the cervix: site of first focus of invasion[J]. Obstet Gynecol, 2001, 97(6): 890-892.
[13]
Solomon D, Stoler M, Jeronimo J, et al. Diagnostic utility of endocervical curettage in women undergoing colposcopy for equivocal or low-grade cytologic abnormalities[J]. Obstet Gynecol, 2007, 110(2): 288-295.
